ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx) (2015)
Andrade, Daniel Ciampi Araujo de ; Teixeira, Manoel Jacobsen ; Galhardoni, Ricardo; Ferreira, Karine A. S. L.; Malieno, Paula Braz; Scisci, Nathalia; Riechelmann, Rachel Pimenta; Teixeira, William Gemio Jacobsen ; Saragiotto, Daniel Fernandes; Silva, Valquiria Aparecida da ; Raicher, Irina; Castro, Isac de; Parravano, Daniella; Fukushima, Julia Tizue; Lefaucheur, Jean-Pascal; Bouhassira, Didier; Macarenco, Ricardo Silvestre e Silva; Mello, Evandro Sobroza de; Hoff, Paulo Marcelo
Source: Journal of Clinical Oncology. Conference titles: ASCO Annual Meeting. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (TERAPIA), QUIMIOTERAPIA, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO (ETIOLOGIA), ANTINEOPLÁSICOS (CLASSIFICAÇÃO;EFEITOS ADVERSOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Daniel Ciampi Araujo de et al. A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/3575?sid=69988bce-10fd-4808-a054-d0c1d39d5fff. Acesso em: 25 abr. 2026. , 2015
APA
Andrade, D. C. A. de, Teixeira, M. J., Galhardoni, R., Ferreira, K. A. S. L., Malieno, P. B., Scisci, N., et al. (2015). A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx). Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/3575?sid=69988bce-10fd-4808-a054-d0c1d39d5fff
NLM
Andrade DCA de, Teixeira MJ, Galhardoni R, Ferreira KASL, Malieno PB, Scisci N, Riechelmann RP, Teixeira WGJ, Saragiotto DF, Silva VA da, Raicher I, Castro I de, Parravano D, Fukushima JT, Lefaucheur J-P, Bouhassira D, Macarenco RS e S, Mello ES de, Hoff PM. A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx) [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2026 abr. 25 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/3575?sid=69988bce-10fd-4808-a054-d0c1d39d5fff
Vancouver
Andrade DCA de, Teixeira MJ, Galhardoni R, Ferreira KASL, Malieno PB, Scisci N, Riechelmann RP, Teixeira WGJ, Saragiotto DF, Silva VA da, Raicher I, Castro I de, Parravano D, Fukushima JT, Lefaucheur J-P, Bouhassira D, Macarenco RS e S, Mello ES de, Hoff PM. A phase III, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of pregabalin in the prevention and reduction of oxaliplatin-induced painful neuropathy (PreOx) [Internet]. Journal of Clinical Oncology. 2015 ; 33( 15S ):[citado 2026 abr. 25 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/15_suppl/3575?sid=69988bce-10fd-4808-a054-d0c1d39d5fff
Artigo de periodico
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy (2015)
Ruff, Paul; Ferry, David R.; Lakomỳ, Radek; McWalter, Gael; Van Hazel, Guy A.; Hoff, Paulo M.; Cunningham, David; Arnold, Dirk; Schmoll, Hans J.; Moiseyenko, Vladimir M.; McKendrick, Joseph J.; ten Tije, Albert J.; Vishwanath, Raghu L.; Bhargava, Pankaj; Chevalier, Soazig; Macarulla, Teresa; Cutsem, Eric Van
Source: European Journal of Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (TERAPIA), FATORES DE CRESCIMENTO, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUFF, Paul et al. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer, v. 51, n. 1, p. 18-26, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2014.10.019. Acesso em: 25 abr. 2026.
APA
Ruff, P., Ferry, D. R., Lakomỳ, R., McWalter, G., Van Hazel, G. A., Hoff, P. M., et al. (2015). Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer, 51( 1), 18-26. doi:10.1016/j.ejca.2014.10.019
NLM
Ruff P, Ferry DR, Lakomỳ R, McWalter G, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Cutsem EV. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [Internet]. European Journal of Cancer. 2015 ; 51( 1): 18-26.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.ejca.2014.10.019
Vancouver
Ruff P, Ferry DR, Lakomỳ R, McWalter G, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Cutsem EV. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [Internet]. European Journal of Cancer. 2015 ; 51( 1): 18-26.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.ejca.2014.10.019
Trabalho de evento-resumo periodico
Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community (2015)
Protasio, Bruno Mendonca; Matutino, Adriana Reis Brandao; Lage, Liana Valente; De Santana, Iuri Amorim; Ramos, Ricardo Emanuel De Oliveira; Caires-Lima, Rafael; Caires, Inacelli Queiroz De Souza; Riechelmann, Rachel Pimenta; Saragiotto, Daniel Fernandes; Sabbaga, Jorge; Hoff, Paulo Marcelo
Source: Journal of Clinical Oncology. Conference titles: Gastrointestinal Cancers Symposium. Unidade: FM
Subjects: QUIMIOTERAPIA (EFEITOS ADVERSOS), NEOPLASIAS COLORRETAIS (TERAPIA), TOXICIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PROTASIO, Bruno Mendonca et al. Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b. Acesso em: 25 abr. 2026. , 2015
APA
Protasio, B. M., Matutino, A. R. B., Lage, L. V., De Santana, I. A., Ramos, R. E. D. O., Caires-Lima, R., et al. (2015). Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b
NLM
Protasio BM, Matutino ARB, Lage LV, De Santana IA, Ramos REDO, Caires-Lima R, Caires IQDS, Riechelmann RP, Saragiotto DF, Sabbaga J, Hoff PM. Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community [Internet]. Journal of Clinical Oncology. 2015 ; 33( 3S ):[citado 2026 abr. 25 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b
Vancouver
Protasio BM, Matutino ARB, Lage LV, De Santana IA, Ramos REDO, Caires-Lima R, Caires IQDS, Riechelmann RP, Saragiotto DF, Sabbaga J, Hoff PM. Safety and efficacy of adjuvant modified FLOX for patients (pts) with stage III colorectal cancer (CRC) treated in the community [Internet]. Journal of Clinical Oncology. 2015 ; 33( 3S ):[citado 2026 abr. 25 ] Available from: http://meeting.ascopubs.org/cgi/content/abstract/33/3_suppl/760?sid=58f206fe-c1f4-43bf-bb03-b609e9edf49b
Artigo de periodico
Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer (2015)
Lopes-Ramos, Camila; Koyama, Fernanda C.; Habr-Gama, Angelita; Salim, Anna Christina M.; Bettoni, Fabiana; Asprino, Paula F.; França, Gustavo S.; Gama-Rodrigues, Joaquim; Parmigiani, Raphael B.; Perez, Rodrigo O.; Galante, Pedro A. F.; Camargo, Anamaria A.
Source: Cancer Genetics. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (TERAPIA), QUIMIOTERAPIA ADJUVANTE, CO-TERAPIA, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES-RAMOS, Camila et al. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer. Cancer Genetics, v. 208, n. 6, p. 319-326, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.cancergen.2015.03.010. Acesso em: 25 abr. 2026.
APA
Lopes-Ramos, C., Koyama, F. C., Habr-Gama, A., Salim, A. C. M., Bettoni, F., Asprino, P. F., et al. (2015). Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer. Cancer Genetics, 208( 6), 319-326. doi:10.1016/j.cancergen.2015.03.010
NLM
Lopes-Ramos C, Koyama FC, Habr-Gama A, Salim ACM, Bettoni F, Asprino PF, França GS, Gama-Rodrigues J, Parmigiani RB, Perez RO, Galante PAF, Camargo AA. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer [Internet]. Cancer Genetics. 2015 ; 208( 6): 319-326.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.cancergen.2015.03.010
Vancouver
Lopes-Ramos C, Koyama FC, Habr-Gama A, Salim ACM, Bettoni F, Asprino PF, França GS, Gama-Rodrigues J, Parmigiani RB, Perez RO, Galante PAF, Camargo AA. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer [Internet]. Cancer Genetics. 2015 ; 208( 6): 319-326.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.cancergen.2015.03.010
Artigo de periodico
Chemotherapy for Patients with Colorectal Liver Metastases Who Underwent Curative Resection Improves Long-Term Outcomes: Systematic Review and Meta-analysis (2015)
Araujo, Raphael L. C.; Gönen, Mithat; Herman, Paulo
Source: Annals of Surgical Oncology. Unidade: FM
Subjects: REVISÃO SISTEMÁTICA, NEOPLASIAS HEPÁTICAS (ETIOLOGIA), NEOPLASIAS COLORRETAIS (TERAPIA), QUIMIOTERAPIA, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Raphael L. C. e GÖNEN, Mithat e HERMAN, Paulo. Chemotherapy for Patients with Colorectal Liver Metastases Who Underwent Curative Resection Improves Long-Term Outcomes: Systematic Review and Meta-analysis. Annals of Surgical Oncology, v. 22, n. 9, p. 3070-3078, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1245%2Fs10434-014-4354-6. Acesso em: 25 abr. 2026.
APA
Araujo, R. L. C., Gönen, M., & Herman, P. (2015). Chemotherapy for Patients with Colorectal Liver Metastases Who Underwent Curative Resection Improves Long-Term Outcomes: Systematic Review and Meta-analysis. Annals of Surgical Oncology, 22( 9), 3070-3078. doi:10.1245/s10434-014-4354-6
NLM
Araujo RLC, Gönen M, Herman P. Chemotherapy for Patients with Colorectal Liver Metastases Who Underwent Curative Resection Improves Long-Term Outcomes: Systematic Review and Meta-analysis [Internet]. Annals of Surgical Oncology. 2015 ; 22( 9): 3070-3078.[citado 2026 abr. 25 ] Available from: http://link.springer.com/article/10.1245%2Fs10434-014-4354-6
Vancouver
Araujo RLC, Gönen M, Herman P. Chemotherapy for Patients with Colorectal Liver Metastases Who Underwent Curative Resection Improves Long-Term Outcomes: Systematic Review and Meta-analysis [Internet]. Annals of Surgical Oncology. 2015 ; 22( 9): 3070-3078.[citado 2026 abr. 25 ] Available from: http://link.springer.com/article/10.1245%2Fs10434-014-4354-6
Artigo de periodico
Perspectivas no cuidado dos tumores gastrointestinais (2014)
Hoff, Paulo; Braghiroli, Maria Ignez; Crosara, Marcela
Source: Revista Onco& -Oncologia para todas as especialidades. Unidade: FM
Subjects: RELATÓRIOS, NEOPLASIAS COLORRETAIS (TERAPIA), NEOPLASIAS GASTROINTESTINAIS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOFF, Paulo e BRAGHIROLI, Maria Ignez e CROSARA, Marcela. Perspectivas no cuidado dos tumores gastrointestinais. Revista Onco& -Oncologia para todas as especialidades, v. 4, n. 24, p. 26-29, 2014Tradução . . Disponível em: http://issuu.com/revista-onco/docs/onco_ed._24. Acesso em: 25 abr. 2026.
APA
Hoff, P., Braghiroli, M. I., & Crosara, M. (2014). Perspectivas no cuidado dos tumores gastrointestinais. Revista Onco& -Oncologia para todas as especialidades, 4( 24), 26-29. Recuperado de http://issuu.com/revista-onco/docs/onco_ed._24
NLM
Hoff P, Braghiroli MI, Crosara M. Perspectivas no cuidado dos tumores gastrointestinais [Internet]. Revista Onco& -Oncologia para todas as especialidades. 2014 ; 4( 24): 26-29.[citado 2026 abr. 25 ] Available from: http://issuu.com/revista-onco/docs/onco_ed._24
Vancouver
Hoff P, Braghiroli MI, Crosara M. Perspectivas no cuidado dos tumores gastrointestinais [Internet]. Revista Onco& -Oncologia para todas as especialidades. 2014 ; 4( 24): 26-29.[citado 2026 abr. 25 ] Available from: http://issuu.com/revista-onco/docs/onco_ed._24
Artigo de periodico
Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy (2013)
Spencer, S. K. M.; Pommier, A. J. C.; Morgan, S. R.; Barry, S. T.; Robertson, J. D.; Hoff, P. M.; Jürgensmeier, J. M.
Source: British Journal of Cancer. Unidade: FM
Subjects: BIOMARCADORES, NEOPLASIAS COLORRETAIS (TERAPIA), ANTINEOPLÁSICOS (APLICAÇÕES TERAPÊUTICAS), PROGNÓSTICO, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPENCER, S. K. M. et al. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. British Journal of Cancer, v. 109, n. 11, p. 2765-2773, 2013Tradução . . Disponível em: https://doi.org/10.1038/bjc.2013.649. Acesso em: 25 abr. 2026.
APA
Spencer, S. K. M., Pommier, A. J. C., Morgan, S. R., Barry, S. T., Robertson, J. D., Hoff, P. M., & Jürgensmeier, J. M. (2013). Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy. British Journal of Cancer, 109( 11), 2765-2773. doi:10.1038/bjc.2013.649
NLM
Spencer SKM, Pommier AJC, Morgan SR, Barry ST, Robertson JD, Hoff PM, Jürgensmeier JM. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2765-2773.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1038/bjc.2013.649
Vancouver
Spencer SKM, Pommier AJC, Morgan SR, Barry ST, Robertson JD, Hoff PM, Jürgensmeier JM. Prognostic/predictive value of 207 serum factors in colorectal cancer treated with cediranib and/or chemotherapy [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2765-2773.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1038/bjc.2013.649
Artigo de periodico
Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects (2013)
Ferreira, A. K.; Santana-Lemos, Bárbara Amélia Aparecida; Rego, Eduardo Magalhaes; Filho, O M R; Chierice, Gilberto Orivaldo; Maria, D. A.
Source: British Journal of Cancer. Unidades: FMRP, IQSC
Subjects: LEUCEMIA, NEOPLASIAS COLORRETAIS (TERAPIA), ANTINEOPLÁSICOS (APLICAÇÕES TERAPÊUTICAS), METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, A. K. et al. Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects. British Journal of Cancer, v. 109, n. 11, p. 2819-2828, 2013Tradução . . Disponível em: https://doi.org/10.1038/bjc.2013.510. Acesso em: 25 abr. 2026.
APA
Ferreira, A. K., Santana-Lemos, B. A. A., Rego, E. M., Filho, O. M. R., Chierice, G. O., & Maria, D. A. (2013). Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects. British Journal of Cancer, 109( 11), 2819-2828. doi:10.1038/bjc.2013.510
NLM
Ferreira AK, Santana-Lemos BAA, Rego EM, Filho OMR, Chierice GO, Maria DA. Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2819-2828.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1038/bjc.2013.510
Vancouver
Ferreira AK, Santana-Lemos BAA, Rego EM, Filho OMR, Chierice GO, Maria DA. Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects [Internet]. British Journal of Cancer. 2013 ; 109( 11): 2819-2828.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1038/bjc.2013.510
Artigo de periodico
Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity (2012)
Hoff, Paulo M.; Saad, Everardo D.; Costa, Frederico; Coutinho, Anelisa K.; Caponero, Ricardo; Prolla, Gabriel; Gansl, Rene C.
Source: Clinical Colorectal Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (TERAPIA), DROGATERAPIA (TOXIDADE), METÁSTASE NEOPLÁSICA, ANTINEOPLÁSICOS (TOXIDADE), MANIFESTAÇÕES NEUROLÓGICAS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOFF, Paulo M. et al. Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity. Clinical Colorectal Cancer, v. 11, n. 2, p. 93-100, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.clcc.2011.10.004. Acesso em: 25 abr. 2026.
APA
Hoff, P. M., Saad, E. D., Costa, F., Coutinho, A. K., Caponero, R., Prolla, G., & Gansl, R. C. (2012). Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity. Clinical Colorectal Cancer, 11( 2), 93-100. doi:10.1016/j.clcc.2011.10.004
NLM
Hoff PM, Saad ED, Costa F, Coutinho AK, Caponero R, Prolla G, Gansl RC. Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity [Internet]. Clinical Colorectal Cancer. 2012 ; 11( 2): 93-100.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.clcc.2011.10.004
Vancouver
Hoff PM, Saad ED, Costa F, Coutinho AK, Caponero R, Prolla G, Gansl RC. Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity [Internet]. Clinical Colorectal Cancer. 2012 ; 11( 2): 93-100.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/j.clcc.2011.10.004

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Indexado em